Terry Smith Fundsmith LLP
Terry Smith is the founder and CEO of Fundsmith, a firm known for a concentrated portfolio of high-quality global companies. His approach favors simple, understandable businesses with high returns on capital and the ability to reinvest at attractive rates. Smith’s annual letters and plain-spoken commentary have made Fundsmith a frequent reference point for long-only quality investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Non-Voting
MKC
|
+$247M |
| 2 |
Philip Morris
PM
|
+$161M |
| 3 |
Johnson & Johnson
JNJ
|
+$111M |
| 4 |
Visa
V
|
+$54.7M |
| 5 |
Intuit
INTU
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$1.3M |
| 2 |
Marriott International
MAR
|
+$451K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.73% |
| 2 | Consumer Staples | 23.75% |
| 3 | Technology | 22.32% |
| 4 | Financials | 14.96% |
| 5 | Communication Services | 6.51% |
Similar funds
Terry Smith's Q2 2019 Portfolio in Review
As of Q2 2019, Terry Smith held 31 positions worth $19.2B, up 9.1% from $17.6B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Terry Smith deployed $837M of net new capital in Q2 2019, adding to 27 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was 3M, an estimated $1.3M trimmed.
- Terry Smith added most to McCormick & Company Non-Voting in Q2 2019, an estimated $247M increase.
- Terry Smith's biggest Q2 2019 reduction was 3M, cutting an estimated $1.3M.
- Terry Smith's ten largest holdings make up 67% of its $19.2B portfolio in Q2 2019.
- Terry Smith opened 0 new positions and closed 0 in Q2 2019.
- Terry Smith's portfolio value rose 9.1% quarter-over-quarter to $19.2B.
Based on Fundsmith LLP's 13F filing for Q2 2019, filed 9 Aug 2019.